Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-10-07Clinical Trial Update: A Support Program for Carers of Persons With Dementia [NA]
This entry reports the completion of a clinical trial evaluating a support program for carers of people with dementia.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Relapse Prevention for Bipolar Type-II Disorder [Phase 4]
Phase 4 relapse-prevention clinical trial in bipolar disorder (including Bipolar Type II) with co-occurring depression has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Sertraline for Alcohol Dependence and Depression [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating sertraline for alcohol use disorder and depression. The study wa…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Multicenter Comparative Study of the Activity of the Medial Prefrontal Cortex in Vulnerability to Depression
A multicenter study assessing medial prefrontal cortex activity as a predictor of vulnerability to major depressive disorder; the trial stat…
-
FDA approval · 2015-10-05FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for the olanzapine and fluoxetine combination (Symbyax) submitted by Par Health USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Comparative Trial of Antidepressant Treatment Models in HIV Care in Uganda [Phase 4]
Phase 4 trial in Uganda evaluating antidepressant treatment models for people with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients [NA]
ClinicalTrials.gov update on a feasibility and tolerability study of adjunct chronotherapy (light therapy) in hospitalized patients with maj…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial [Phase 2, Phase 3]
A double-blind randomized trial (Phase 2/3) assessed the efficacy of Nepeta menthoides extract for anxiety in patients with depression, with…
-
CLINICAL_TRIALS trial_result · 2015-10-01Clinical Trial Update: Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression [Phase 4]
Phase 4 trial comparing an antidepressant plus asenapine to an antidepressant plus placebo in adults with major depressive disorder without …
-
FDA approval · 2015-09-30FDA Approved: ARIPIPRAZOLE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s Original Application for aripiprazole, granting approval of a generic version of the antipsychotic.
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: TNS for Treating Major Depressive Disorder in the Elderly [Phase 1, Phase 2]
This clinical trial update describes Phase 1/Phase 2 studies evaluating transcutaneous nerve stimulation (TNS) for major depressive disorder…
-
CLINICAL_TRIALS research · 2015-09-28Clinical Trial Update: Evaluation of Two Community-based Mental Health Interventions for Violence-Displaced Afro-Descendants in Colombia. [NA]
Clinical trial evaluating two community-based mental health interventions for violence-displaced Afro-Descendants in Colombia; completed wit…
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Facilitating Implementation of Cognitive Behavioral Therapy in Primary Care and Community Clinics [NA]
This clinical trial update describes efforts to facilitate the implementation of cognitive behavioral therapy in primary care and community …
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Improving Depression Outcome by Enhancing Memory for Cognitive Therapy [Phase 2]
This update notes the completion of a Phase 2 trial evaluating whether enhancing memory can improve outcomes of cognitive therapy for major …
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Trial of Transcranial Direct Current Stimulation (tDCS) for Depression [Phase 2]
A Phase 2 clinical trial evaluating transcranial direct current stimulation (tDCS) for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Trial of Bilateral tDCS for Depression [Phase 1, Phase 2]
A clinical trial update indicates the Phase 1 and Phase 2 trials of bilateral transcranial direct current stimulation for major depressive d…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Brief Behavioral Intervention for Comorbid Migraine and Depression [NA]
Completed clinical trial evaluating a brief behavioral intervention for comorbid migraine and depression; results posted in 2015.
-
CLINICAL_TRIALS research · 2015-09-15Clinical Trial Update: Jump Step - A Participatory Approach to Physical Activity & Mental Wellness [NA]
An update on a university-led trial (Jump Step) examining physical activity and mental wellness for individuals with major depressive disord…
-
FDA approval · 2015-09-11FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for generic bupropion hydrochloride from Aurobindo Pharma Limited, confirming continued approval and…
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents [Phase 3]
Phase 3 trial evaluating school-based cognitive behavioral therapy shows effectiveness in preventing depression among young adolescents, wit…
-
FDA approval · 2015-09-09FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS research · 2015-09-09Clinical Trial Update: Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
This clinical trial update describes a study investigating biomarkers associated with fatigue in early-stage breast cancer patients treated …
-
FDA approval · 2015-09-04FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for quetiapine fumarate from Hikma Pharmaceuticals USA, indicating approval of changes to the pr…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients [Phase 4]
Phase 4 clinical trial in Korea evaluating the effect of antidepressants on treatment outcomes for patients with Major Depressive Disorder; …
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes [Phase 1]
Phase 1 pharmacokinetic study evaluating how fluvoxamine and digoxin are affected by different MDR1 genotypes; the study has completed in su…